The Business Journals second annual Wealthy 1000 analysis reveals America's wealthiest ZIP codes. Here are the wealthiest ZIP ...

The war on Iran, for all its complexity and global effects, boils down to a single question: Who can take the pain the longest? A surge in oil prices may ...

TORRANCE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: NVTS), an industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, toda ...

The FDA warned Novo Nordisk over reporting violations related to the deaths of patients taking its weight-loss drug.

Have you noticed the side effects listed for one of those new drugs being advertised on TV? It may seem as if one of those marvelous medicines might be a good solution for your problem, but the long ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

Serious side effects are more likely to occur when taking high doses, particularly in people with certain health conditions like kidney disease or take medications that affect potassium levels.

Patients worried about potential side effects of statins can rest easy, according to a new large-scale study: The vast majority of adverse effects listed on statin medications simply never occur. The ...

Benefits of statins greatly outweigh risks, study leader says Wrongly attributed side effects may discourage use by patients and doctors Regulators should change statin labeling, researchers say Feb 5 ...

The long list of side effects associated with statins is vastly overstated, according to the most rigorous assessment of the evidence to date. This is prompting calls for the drugs’ packaging to be ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...